No | Age/sex | Underlying condition | Medical device | Infection type | Treatment | Outcome | Year/reference |
---|---|---|---|---|---|---|---|
1 | 1 year/M | Burn | Ventilator | VAP | Ciprofloxacin, cefoxitin, amikacin | Died | 1996/Hsueh et al. (1996) |
2 | 5 year/F | Neuroblastoma | CVC | Bacteremia | NR | Survived | 1996/Hsueh et al. (1996) |
3 | 1 year/F | Hepatoblastoma | CVC | Bacteremia | NR | Survived | 1996/Hsueh et al. (1996) |
4 | 2 year/M | Diabetes mellitus (Type 1) | Peripheral catheter | Bacteremia | Ceftriaxone | Survived | 2005/(Cascio et al. 2005) |
5 | 5 month/M | Down syndrome, diaphragmatic hernia, ASD | Ventilator | Bacteremia | Vancomycin, ofloxacin | Died | 2007/(Bayraktar et al. 2007) |
6 | 13 year/M | Congenital hydrocephalus | Lumboperitoneal shunt | Lumboperitoneal shunt infection | TMP–SMX, Rifampin | Survived | 2007/(Al-Tatari et al. 2007) |
7 | 33 day/F | None | None | Bacteremia | Cefepime | Survived | 2010/(Douvoyiannis et al. 2010) |
8 | 2 month/M | Hydrocephaly | External shunt | Meningitis, sepsis | Ampicillin–sulbactam, levofloxacin | Died | 2011/(Ceylan et al. 2011) |
9 | 36 week newborn/NR | Prematurity | Ventilator | Bacteremia | Cefoperazone–sulbactam | Survived | 2011/(Sudharani and Asiya Saxena 2011) |
10 | 20 day/M | Complex congenital heart disease | Ventilator | VAP | Piperacillin–tazobactam | Survived | 2011/(Calderón et al. 2011) |
11 | 8 day/F | None | None | Meningitis | Cefepime | Survived | 2013/(Hendaus and Zahraldin 2013) |
12 | 3 year/F | Acute myeloid leukemia | CVC | CRBSI | Ciprofloxacin, minocycline | Survived | 2013/(Kodama et al. 2013) |
13 | 6 month/M | Congenital hydrocephalus, prematurity | Ventriculoperitoneal shunt | Meningitis | TMP–SMX, cefoperazone–sulbactam | Survived | 2013/(Ozcan et al. 2013) |
14 | 11 month/M | Holoprosencephaly, obstructive hydrocephalus | Ventriculoperitoneal shunt | Meningitis | TMP–SMX, ceftazidime | Survived | 2014/(Olbrich et al. 2014) |
15 | 6 day/F | SGA | None | Meningitis, sepsis | Ciprofloxacin, TMP–SMX | Survived | 2014/(Eshwara et al. 2014) |
16 | 3 month/F | ASD | CVC | Bacteremia | TMP–SMX | Survived | 2014/(Aydin et al. 2014) |
17 | 27 week newborn/F | Complex congenital heart disease | Central catheter, arterial and venous line | Bacteremia | Ciprofloxacin, imipenem | Survived | 2014/(Alford and Shelton 2014) |
18 | 3 month/M | Metabolic disease | CVC, ventilator | CRBSI | Ciprofloxacin, imipenem, colimycin, linezolid | Died | 2016/(Aykac et al. 2016) |
19 | 2 year/F | Congenital hydrocephalus | External shunt | Meningitis | Ciprofloxacin, TMP–SMX | Survived | 2016/(Aykac et al. 2016) |
20 | 8 year/M | Cystic fibrosis, nephrotic syndrome | None | Pneumonia | Ceftriaxone | Survived | 2016/(Aykac et al. 2016) |
21 | 8 month/M | Ileus | CVC | Bacteremia | Ciprofloxacin, meropenem, vancomycin | Survived | 2016/(Aykac et al. 2016) |
22 | 16 month/F | ITP, immunosuppressive therapy | None | Bacteremia | Ceftriaxone | Survived | 2016/(Aykac et al. 2016) |
23 | 3 year/F | Cerebral palsy | CVC | CRBSI | Meropenem, amikacin | Survived | 2016/(Aykac et al. 2016) |
24 | 11 year/F | None | None | Soft tissue infection | Ceftazidime, metronidazole | Survived | 2016/(Srinivasan et al. 2016) |
25 | 3 month/F | Meningomyelocele, congenital diaphragmatic hernia | Ventilator | VAP | Ciprofloxacin | Survived | Our case |